PHARMASEAL
Nottingham
About PHARMASEAL
PHARMASEAL was born in 2016 with the mission to create a digital platform that enables their customers to increase control of their clinical trials and accelerate product development. PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.8M
- Last round: Equity Crowdfunding (Sep 2020)
- Website: pharmaseal.co
- Phone: +44(0)1157486712
Industries & Categories
Biopharma, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharmaseal-120791 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.